Search

everythinglearnresearchcommunity

for

Search:↓

CGF injections may safely and effectively promote hair growth in androgenetic alopecia patients.

Quercetin nanocrystal gel shows promise for hair regrowth in androgenetic alopecia.

Exosomes from hair papilla cells and the Chinese medicine Liao Tuo Fang can potentially promote hair growth and could be used to develop hair growth drugs.

Finasteride improves heart function in obese and aging male rats by reducing oxidative stress and p53 protein levels.

Dutasteride 0.5mg is more effective than finasteride 1mg for treating male pattern baldness.

Nutrition plays a key role in managing skin disorders, with specific dietary changes helping improve conditions like acne, dermatitis, psoriasis, alopecia, and skin cancer.

Dr. Min's method for eyebrow and eyelash transplantation is effective, with most hairs regrowing, and proper recovery is crucial for success.

Terminalia bellirica extract may help promote hair growth and prevent hair loss caused by testosterone.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Neurosteroids help control dopamine responses in the brain.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

Women with a certain type of hair loss have more copper in the back of their head than the front, and treatment can normalize hair but not copper levels.

Osteopathic manipulation therapy might help treat dementia caused by finasteride.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

Methylation of the 5-AR2 gene may cause resistance to Finasteride in BPH patients.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.